Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0220 per EA under NDC 75834026601. Its NADAC has been published 207 times since Mar 24, 2021.
FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.
Strength
5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834026601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696FDA Approved
5/3/2018
TE Code
BX
On Market Since
2/15/2021
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 207 times since Mar 24, 2021, and over the history we have for it it has declined 20.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0220 per EA |
|---|---|
| All-time high | $0.0314 (Nov 16, 2022) |
| All-time low | $0.0174 (Nov 20, 2024) |
| Median price | $0.0266 |
| Average price | $0.0260 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | Mar 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-15.2%
5Y
-17.5%
All
-20.0%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0220 per EA (NDC 75834026601), effective Mar 5, 2025.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 20.0%. It has been tracked across 207 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Mar 24, 2021, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0266 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 5 MG TABLET, is $0.0217 per EA — about 1% below BUSPIRONE HCL 5 MG TABLET.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 75834026601) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.